ERTC Members

Initiated in 2004, the EURORDIS Round Table of Companies (ERTC) is a “club” of pharmaceutical companies with a common interest in rare diseases and orphan drug development.

Members agree to financially support EURORDIS activities and benefit from the development of a fruitful exchange between EURORDIS itself, government and regulatory authorities, academics and patients representatives. These exchanges mainly take place at closed bi-annual ERTC Workshops. Three levels of membership exist -Sapphire, Emerald and Ruby - the last one corresponding to the largest financial contribution.

Companies interested in the challenging field of rare disease are invited to become members of the EURORDIS Round Table of Companies. More about ERTC membership

Current Members

 
• Ruby Members
     
Alnylam Celgene CLS Behring IQVIA Logo Novartis Pharmaceuticals
Pfizer Roche Genzyme Shire Pharmaceuticals, Inc  
• Emerald Members
     
Ablinx Achillion Actelion Website Akcea Alexion Pharmaceuticals Inc.
Bristol-Myers Squibb/AstraZeneca Audentes Avexis Biogen Biomarin
Bluebird Bio Boehringer Ingelheim GmbH BMS Cytokinetics GRIFOLS
GlaxoSmithKline Horizon Pharma USA INC Research/inventive Health Incyte ipsen

EUSA pHARMA

KYOWA KIRIN LFB mapi MSD Europe

Orphan Europe

PTC Therapeutics

Swedish Orphan International

Vanda Pharmaceuticals/ Vertex

Wave Life Sciences

 

 

   
• Sapphire Members
     
Aegerion Agios Amgen Akari Amicus Therapeutics
Bayer Schering Pharma AG Biopontis Alliance Chiesi Farmaceutici SpA Clinigen Group Cydan
DLA Piper Dompé Group EDITAS ENZYVANT Généthon
insmed Inceptua insmed Mark Krueger & Associates  Inc. Leadiant biosciences
Ovid PharmaMar Prometic RegenXBio
Sangamo Santhera Spark UCB
Ultragenyx Vifor Fresenius Medical Care  
• Associate Members
     
Lysogene-Q    

* In-Kind member acting as liaison with NORD Corporate Council in the US and in recognition of support of the ERTC workshop dinners


Disclaimer
EURORDIS is not responsible for any content of other websites accessible from this page, nor does it endorse or in any respect warrant any third party products or services by virtue of any information, material or content referred to or included on, or linked from or to the EURORDIS website. EURORDIS does not endorse medicinal products, brands or health services.

 


Author: EURORDIS

 

>

Page created: 19/08/2009
Page last updated: 21/11/2017
 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases